Literature DB >> 17470533

Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105.

Senad Divanovic1, Aurelien Trompette, Lisa K Petiniot, Jessica L Allen, Leah M Flick, Yasmine Belkaid, Rajat Madan, Jennifer J Haky, Christopher L Karp.   

Abstract

As all immune responses have potential for damaging the host, tight regulation of such responses--in amplitude, space, time and character--is essential for maintaining health and homeostasis. It was thus inevitable that the initial wave of papers on the role of Toll-like receptors (TLRs), NOD-like receptors (NLRs) and RIG-I-like receptors (RLRs) in activating innate and adaptive immune responses would be followed by a second wave of reports focusing on the mechanisms responsible for restraining and modulating signaling by these receptors. This overview outlines current knowledge and controversies about the immunobiology of the RP105/MD-1 complex, a modulator of the most robustly signaling TLR, TLR4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470533     DOI: 10.1189/jlb.0107021

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  23 in total

1.  Crystal structure of soluble MD-1 and its interaction with lipid IVa.

Authors:  Sung-il Yoon; Minsun Hong; Gye Won Han; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

Review 3.  Toll-like receptors: lessons to learn from normal and malignant human B cells.

Authors:  David Chiron; Isabelle Bekeredjian-Ding; Catherine Pellat-Deceunynck; Régis Bataille; Gaëtan Jego
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

4.  RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling.

Authors:  Bo Liu; Naisheng Zhang; Zhicheng Liu; Yunhe Fu; Shuang Feng; Shan Wang; Yongguo Cao; Depeng Li; Dejie Liang; Fengyang Li; Xiaojing Song; Zhengtao Yang
Journal:  Mol Cell Biochem       Date:  2013-03-13       Impact factor: 3.396

Review 5.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 6.  The structural biology of Toll-like receptors.

Authors:  Istvan Botos; David M Segal; David R Davies
Journal:  Structure       Date:  2011-04-13       Impact factor: 5.006

7.  Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway.

Authors:  Jay W Chaplin; Shinji Kasahara; Edward A Clark; Jeffrey A Ledbetter
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

8.  An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1.

Authors:  Sung-il Yoon; Minsun Hong; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2011-08-21       Impact factor: 15.369

9.  Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.

Authors:  Jun-Ichi Satoh; Yoshihiro Shimamura; Hiroko Tabunoki
Journal:  Cell Mol Neurobiol       Date:  2011-11-12       Impact factor: 5.046

Review 10.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.

Authors:  Derek S Wheeler; Basilia Zingarelli; William J Wheeler; Hector R Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.